期刊文献+

膀胱癌肿瘤组织中bcl-x基因mRNA的表达及其临床意义 被引量:3

The mRNA Expression of Bcl-x Gene in Bladder Cancer Tissues and Its Clinical Significance
下载PDF
导出
摘要 【目的】研究凋亡调控基因bcl x在膀胱癌患者肿瘤组织中的表达情况 ,探索bcl x基因的异常表达与膀胱癌的发病、演进和复发的关系。【方法】应用半定量逆转录 -聚合酶链反应 (RT PCR)技术检测 30例膀胱癌患者新鲜肿瘤组织和 10例膀胱正常组织标本中bcl x基因mRNA的表达情况。【结果】2 1例膀胱癌组织标本表达bcl xl(70 % ) ,12例表达bcl xs(4 0 % ) ,bcl xl基因mRNA平均表达量明显高于bcl xs基因 ,膀胱癌组织中bcl xs基因与bcl xl基因在表达上呈正相关 ;2例膀胱正常组织标本表达bcl xl(2 0 % ) ,无表达bcl xs者。不同病理分级和病理分期的膀胱癌组织中bcl x基因表达无显著性差异。【结论】膀胱癌组织普遍表达bcl xl基因 ,部分表达bcl xs基因 ,bcl xl基因的表达处于优势地位。膀胱癌的发病与bcl xs无关 ,而与凋亡抑制基因bcl xl的高表达有关。bcl xl基因与膀胱癌的演进和复发有关 ,可作为预计其术后复发风险的一项重要指标。 Objectives]To study the expression of apoptosis-associated B-cell lymphoma-x (bcl-x) gene in the tumor tissues of patients with bladder cancer (BC) and explore the relationship between the abnormal expression of bcl-x gene and the episode, progression and recurrence of BC.The mRNA expressions of bcl-x gene in fresh tumor tissues from 30 BC patients and normal tissues of urinary bladder from 10 healthy subjects were detected by semiquantitative reverse transcriptase-polymerase chain reaction (RT-PCR).The expression rate of bcl-xl gene in tissue specimens from 21 BC patients was 70% and that of bcl-xs gene in 12 BC patients was 40%. The average expression level of bcl-xl gene mRNA was much higher than that of bcl-xs gene ; whereas expression of bcl-xl gene was only found in normal tissues of urinary bladder from 2 healthy subjects (20%), there was no expression of bcl-xs gene simultaneously. In BC tissues with different pathological grades and stages, expression of bcl-xs gene displayed no significant discrepancy. [Conclusion] In tissues of BC, the bcl-xl gene is widely expressed and the bcl-xs gene is partially expressed, exhibiting the superiority of bcl-xl gene expression over bcl-xs gene. The pathogenesis of BC is likely related with the overexpression of apoptosis inhibitory gene bcl-xl, but not with bcl-xs gene. Bcl-xl gene shows close relation to the progression and recurrence of BC and may be used as an important marker for predicting its recurrence risk after operation.
出处 《医学临床研究》 CAS 2004年第3期252-255,共4页 Journal of Clinical Research
关键词 膀胱癌 肿瘤组织 BCL-X基因 MRNA 表达 bladder neoplasms/GE proto-oncogene RNA,messenger
  • 相关文献

参考文献12

  • 1Gazzaniga P, Gradilone A, Giuliani L,et al. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer[J].Ann Oncol,2003,14(1):85-90.
  • 2Haitel A, Posch B, El-Baz M,et al. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2[J].J Urol,2001,165(5):1481-
  • 3Minn AJ, Rudin CM, Boise LH, et al. Expression of Bcl-xl can confer a multidrug resistance phenotype[J].Blood,1995,86(5):1903-1910.
  • 4Reed JC, Miyashita T, Cuddy M, et al. Regulation of p26-bcl-2 protein levels in human peripheral blood lymphocytes[J].Lab Invest,1992 ,67(4):443-449.
  • 5Boise LH, Gonzalez-Garcia M, Postema CE, et al.Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death[J].Cell, 1993,74(4):597-608.
  • 6Shangary S, Johnson DE. Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family[J].Leukemia, 2003, 17(8):1470-1481.
  • 7Biroccio A, Benassi B, D'Agnano I, et al. c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings[J].Am J Pathol,2001,158(4):1289-1299.
  • 8Hattori T, Ookawa N, Fujita R,et al. Heterodimerization of Bcl-2 and Bcl-X(L) with Bax and Bad in colorectal cancer[J].Acta Oncol,2000,39(4):495-500.
  • 9Olopade OI, Adeyanju MO, Safa AR,et al. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases[J].Cancer J Sci Am,1997 ,3(4):230-237.
  • 10Zhang CL, Kamarashev J, Qin JZ,et al. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells[J].J Pathol,2003 ,200(2):249-254.

同被引文献17

  • 1李昕,李建民,杨志平,许复郁.Bcl-x_L及DNA-PKcs在ⅡB期骨肉瘤中的表达及临床意义[J].中国骨肿瘤骨病,2005,4(1):23-26. 被引量:2
  • 2胡静姿,刘惠敏,李玉莉,何金,朱维建.Bcl-2、Bcl-x_L和Bax在结直肠癌中的表达[J].第二军医大学学报,2006,27(3):249-252. 被引量:15
  • 3Ashhab Y, Alian A, Polliack A,et al. Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern[J].FEBS Lett,2001,495(1-2) :56-60.
  • 4Hussein M R, Haemel A K, Wood G S. Apoptosis and melanoma: molecular mechanisms[J]. Pathol, 2003,199(3):275-288.
  • 5Kasof G M, Gomes B C. Livin, a novel inhibitor of apoptosis protein family member[J]. J Biol Chem, 2001,276(5):3238-3246.
  • 6Gazzaniga P, Gradilone A, Giuliani L, et al. Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer[J]. Ann Oncol, 2003,14(1):85-90.
  • 7Shimizu S, Eguchi Y, Kosaka H, et al. Prevention of hypoxia - induced cell death by Bcl - 2 and Bcl - xL[ J ]. Nature, 1995, 374 : 811 -813.
  • 8Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cells survival and oncogenesis[ J]. Oncogene, 2003, 22 : 8590 - 8607.
  • 9Boise LH, Gonzalez GM, Postema CE, et al. Bcl -x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death [J]. Cell, 74:597 -608.
  • 10Groeger AM, Esposito V, De Luca A, et al. Prognoslic value of immuno - histochemical expression of p53, Bax, Bcl - 2 and Bcl - xL in resected non - small - cell lung cancers[ J]. Histopathology, 2004,44 : 54 - 63.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部